Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.

Cite this paper

@article{Aronne2007ProgressiveRI, title={Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.}, author={Louis J. Aronne and Ken N Fujioka and Vanita R. Aroda and Kim S Chen and Amy E. Halseth and Nicole C. Kesty and Colleen M. Burns and Cameron W. Lush and Christian Weyer}, journal={The Journal of clinical endocrinology and metabolism}, year={2007}, volume={92 8}, pages={2977-83} }